Aylin R. Rodan

Aylin R. Rodan

Auto-generated profile, based on publicly available information

Aylin R. Rodan

Molecular Medicine Program, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 1997 in Science
Verified
Journal Article
Closed access
PDF file
KLKui Lin
Kui Lin
JDJennie B. Dorman
Jennie B. Dorman
ARAylin Rodan
Aylin Rodan
CKCynthia Kenyon
Cynthia Kenyon
The wild-type Caenorhabditis elegans nematode ages rapidly, undergoing development, senescence, and death in less than 3 weeks. In contrast, mutants with reduced activity of the gene daf-2, a homolog of the insulin and insulin-like growth factor receptors, age more slowly than normal and live more than twice as long. These mutants are active and fully fertile and have normal metabolic rates. The life-span extension caused by daf-2 mutations requires the activity of the gene daf-16. daf-16 appears to play a unique role in life-span regulation and encodes a member of the hepatocyte nuclear factor 3 (HNF-3)/forkhead family of transcriptional regulators. In humans, insulin down-regulates the expression of certain genes by antagonizing the activity of HNF-3, raising the possibility that aspects of this regulatory system have been conserved.

15 December 2002 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
FWFred W. Wolf
Fred W. Wolf
ARAylin R. Rodan
Aylin R. Rodan
LTLeo L. Tsai
Leo L. Tsai
UHUlrike Heberlein
Ulrike Heberlein
Understanding how ethanol influences behavior is key to deciphering the mechanisms of ethanol action and alcoholism. In mammals, low doses of ethanol stimulate locomotion, whereas high doses depress it. The acute stimulant effect of ethanol has been proposed to be a manifestation of its rewarding effects. In Drosophila, ethanol exposure transiently potentiates locomotor activity in a biphasic dose- and time-dependent manner. An initial short-lived peak of activity corresponds to an olfactory response to ethanol. A second, longer-lasting period of increased activity coincides with rising internal ethanol concentrations; these closely parallel concentrations that stimulate locomotion in mammals. High-resolution analysis of the walking pattern of individual flies revealed that locomotion consists of bouts of activity; bout structure can be quantified by bout frequency, bout length, and the time spent walking at high speeds. Ethanol exposure induces both dramatic and dynamic changes in bout structure. Mutants with increased ethanol sensitivity show distinct changes in ethanol-induced locomotor behavior, as well as genotype-specific changes in activity bout structure. Thus, the overall effect of ethanol on locomotor behavior in Drosophila is caused by changes in discrete quantifiable parameters of walking pattern. The effects of ethanol on locomotion are comparable in flies and mammals, suggesting that Drosophila is a suitable model system to study the underlying mechanisms.

1 June 2001 in Cell
Verified
Journal Article
Closed access
YCYuzhong Cheng
Yuzhong Cheng
KEKeita Endo
Keita Endo
KWKwok Wu
Kwok Wu
ARAylin R. Rodan
Aylin R. Rodan
UHUlrike Heberlein
Ulrike Heberlein
RDRonald L Davis
Ronald L Davis

1 July 2021 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
LALaith Farah Al-Rabadi
Laith Farah Al-Rabadi
TCTiffany Caza
Tiffany Caza
CTClaire Trivin-Avillach
Claire Trivin-Avillach
ARAylin R. Rodan
Aylin R. Rodan
NANicole Andeen
Nicole Andeen
LBLaurence H. Beck
Laurence H. Beck
Significance Statement: Membranous nephropathy (MN) is a glomerular disease that often leads to nephrotic syndrome and is caused by autoantibodies that target podocyte proteins. Recent work has identified new targets in this disease, although many cases remain untyped, making clinical monitoring difficult. A combination of conventional and more novel techniques reveals a new target podocyte antigen in MN, serine protease HTRA1. Fourteen patients were identified in a demographic group with mean age of 67.3 years. The titer of circulating anti-HTRA1 antibodies appears to correlate with the disease course, suggesting serial monitoring could facilitate diagnostic and therapeutic decisions. Study of the function of HTRA1 may provide important clues to podocyte biology and the underlying pathogenesis of this type of MN. Background: Identification of target antigens PLA2R, THSD7A, NELL1, or Semaphorin-3B can explain the majority of cases of primary membranous nephropathy (MN). However, target antigens remain unidentified in 15%–20% of patients. Methods: A multipronged approach, using traditional and modern technologies, converged on a novel target antigen, and capitalized on the temporal variation in autoantibody titer for biomarker discovery. Immunoblotting of human glomerular proteins followed by differential immunoprecipitation and mass spectrometric analysis was complemented by laser-capture microdissection followed by mass spectrometry, elution of immune complexes from renal biopsy specimen tissue, and autoimmune profiling on a protein fragment microarray. Results: These approaches identified serine protease HTRA1 as a novel podocyte antigen in a subset of patients with primary MN. Sera from two patients reacted by immunoblotting with a 51-kD protein within glomerular extract and with recombinant human HTRA1, under reducing and nonreducing conditions. Longitudinal serum samples from these patients seemed to correlate with clinical disease activity. As in PLA2R- and THSD7A- associated MN, anti-HTRA1 antibodies were predominantly IgG4, suggesting a primary etiology. Analysis of sera collected during active disease versus remission on protein fragment microarrays detected significantly higher titers of anti-HTRA1 antibody in active disease. HTRA1 was specifically detected within immune deposits of HTRA1-associated MN in 14 patients identified among three cohorts. Screening of 118 “quadruple-negative” (PLA2R-, THSD7A-, NELL1-, EXT2-negative) patients in a large repository of MN biopsy specimens revealed a prevalence of 4.2%. Conclusions: Conventional and more modern techniques converged to identify serine protease HTRA1 as a target antigen in MN.

1 November 2002 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ARAylin R. Rodan
Aylin R. Rodan
JKJohn A. Kiger
John A. Kiger
UHUlrike Heberlein
Ulrike Heberlein
Ethanol has complex but similar effects on behavior in mammals and the fruit fly Drosophila melanogaster. In addition, genetic and pharmacological approaches have implicated the cAMP pathway in the regulation of ethanol-induced behaviors in both flies and rodents. Here we examine the neuroanatomical loci that modulate ethanol sensitivity in Drosophila by targeting the expression of an inhibitor of cAMP-dependent protein kinase (PKA) to specific regions in the fly9s brain. Expression of the inhibitor in most brain regions or in muscle has no effect on behavior. In contrast, inhibition of PKA in a relatively small number of cells, possibly neurosecretory cells, in the fly9s brain is sufficient to decrease sensitivity to the incoordinating effects of ethanol. Additional brain areas are, however, also involved. The mushroom bodies, brain structures where cAMP signaling is required for olfactory classical conditioning, are dispensable for the regulation of ethanol sensitivity. Finally, different behavioral effects of ethanol, motor incoordination and sedation, appear to be regulated by PKA function in distinct brain regions. We conclude that the regulation of ethanol-induced behaviors by PKA involves complex interactions among groups of cells that mediate either increased or reduced sensitivity to the acute intoxicating effects of ethanol.

12 December 2004 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ACAmmon B Corl
Ammon B Corl
ARAylin R Rodan
Aylin R Rodan
UHUlrike Heberlein
Ulrike Heberlein